Mahiuddin Ahmed serves as Executive at Y-mAbs Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mahiuddin Ahmed has executed 5 insider transactions totaling $4.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on May 26, 2020 involved selling 50,000 shares valued at $2.0M.
Mahiuddin Ahmed currently holds 150,000 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mahiuddin Ahmed has been a net seller of YMAB stock. They have purchased $0 and sold $4.3M worth of shares.
Mahiuddin Ahmed's most recent insider trade was on May 26, 2020, when they sold 50,000 shares at $39.38 per share.
Get notified when new Form 4 filings are submitted
| $39.24 |
| Discretionary |
| May 18, 2020 | YMAB | $769.7K | Sale | 19,492 | $39.49 | Discretionary |
| May 13, 2020 | YMAB | $395.5K | Sale | 10,508 | $37.64 | Discretionary |
| May 12, 2020 | YMAB | $783.8K | Sale | 20,000 | $39.19 | Discretionary |